Drug Profile
PGL 2
Alternative Names: E2MATE; Estradiol sulfamate; Estradiol-3-O-sulfamate; J 995 - PregLem; J-995; PGL-2001; ZK-190628Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Jenapharm
- Developer PregLem
- Class Estradiol congeners
- Mechanism of Action Steryl sulfatase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Endometriosis
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for phase-I development in Endometriosis in Germany (PO, Tablet)
- 04 Nov 2017 No recent reports of development identified for phase-I development in Endometriosis in Switzerland (PO, Tablet)
- 17 Jun 2015 PGL 2 (PGL2001) is still in phase-IIa development for Endometriosis in Europe